{"transactions":[{"id":743035,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:38:23.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":78732,"source":{"system":"sec-edgar","filing":"0001628280-26-042130","document":"wk-form4_1781113100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042130/wk-form4_1781113100.xml","form_type":"4"}},{"id":1042738,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T17:55:07.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":11120,"price":17.49,"value":194488.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":44215,"source":{"system":"sec-edgar","filing":"0001296525-25-000002","document":"wk-form4_1757613304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000129652525000002/wk-form4_1757613304.xml","form_type":"4"}},{"id":1113229,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:34:57.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":55335,"source":{"system":"sec-edgar","filing":"0001628280-25-031021","document":"wk-form4_1749760489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031021/wk-form4_1749760489.xml","form_type":"4"}},{"id":1483357,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-11T21:50:28.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-24-027716","document":"wk-form4_1718142621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027716/wk-form4_1718142621.xml","form_type":"4"}},{"id":1483356,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:50:28.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":13286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":45467,"source":{"system":"sec-edgar","filing":"0001628280-24-027716","document":"wk-form4_1718142621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027716/wk-form4_1718142621.xml","form_type":"4"}},{"id":1483355,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:50:28.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":32181,"source":{"system":"sec-edgar","filing":"0001628280-24-027716","document":"wk-form4_1718142621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027716/wk-form4_1718142621.xml","form_type":"4"}},{"id":1801818,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:33:33.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":10061,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-23-029930","document":"wk-form4_1692365605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029930/wk-form4_1692365605.xml","form_type":"4"}},{"id":1801817,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:33:33.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001628280-23-029930","document":"wk-form4_1692365605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029930/wk-form4_1692365605.xml","form_type":"4"}},{"id":1801816,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T13:33:33.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":22120,"source":{"system":"sec-edgar","filing":"0001628280-23-029930","document":"wk-form4_1692365605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029930/wk-form4_1692365605.xml","form_type":"4"}},{"id":1932256,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-03T16:19:49.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001628280-23-010320","document":"wf-form4_168053877805362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010320/wf-form4_168053877805362.xml","form_type":"4"}},{"id":1932255,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T16:19:49.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17483,"source":{"system":"sec-edgar","filing":"0001628280-23-010320","document":"wf-form4_168053877805362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010320/wf-form4_168053877805362.xml","form_type":"4"}},{"id":2067103,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:04:56.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001628280-23-000211","document":"wf-form4_167286627832143.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000211/wf-form4_167286627832143.xml","form_type":"4"}},{"id":2067102,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:04:56.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":16826,"source":{"system":"sec-edgar","filing":"0001628280-23-000211","document":"wf-form4_167286627832143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000211/wf-form4_167286627832143.xml","form_type":"4"}},{"id":2148675,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-30T20:48:46.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001628280-22-025812","document":"wf-form4_166457091189748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025812/wf-form4_166457091189748.xml","form_type":"4"}},{"id":2148674,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T20:48:46.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":16417,"source":{"system":"sec-edgar","filing":"0001628280-22-025812","document":"wf-form4_166457091189748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025812/wf-form4_166457091189748.xml","form_type":"4"}},{"id":2234091,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-13T20:45:15.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":4637,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001213900-22-032531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022032531/ownership.xml","form_type":"4"}},{"id":2311114,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T20:48:45.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001213900-22-017502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022017502/ownership.xml","form_type":"4"}},{"id":2454170,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-03T21:45:19.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":743,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001213900-22-000275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022000275/ownership.xml","form_type":"4"}},{"id":2512640,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (pursuant to 10B5-1 plan)","published_at":"2021-11-15T21:45:27.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":6252,"price":84.38,"value":527543.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on September 7, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":16083,"source":{"system":"sec-edgar","filing":"0001213900-21-059450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021059450/ownership.xml","form_type":"4"}},{"id":2554278,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T20:45:24.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":334,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001213900-21-051138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021051138/ownership.xml","form_type":"4"}},{"id":2649698,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T20:48:47.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":22335,"source":{"system":"sec-edgar","filing":"0001213900-21-035080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021035080/ownership.xml","form_type":"4"}},{"id":2761113,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T16:40:37.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":21928,"source":{"system":"sec-edgar","filing":"0001213900-21-019880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021019880/ownership.xml","form_type":"4"}},{"id":2920111,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:45:55.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":21389,"source":{"system":"sec-edgar","filing":"0001213900-21-000456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000456/ownership.xml","form_type":"4"}},{"id":2920110,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:45:55.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":1183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":20587,"source":{"system":"sec-edgar","filing":"0001213900-21-000456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000456/ownership.xml","form_type":"4"}},{"id":3091671,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:35:15.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":19404,"source":{"system":"sec-edgar","filing":"0001213900-20-016584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/ownership.xml","form_type":"4"}},{"id":3190811,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T12:47:05.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":17467,"source":{"system":"sec-edgar","filing":"0001213900-20-008140","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/ownership.xml","form_type":"4"}},{"id":3316262,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T21:31:02.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":14683,"source":{"system":"sec-edgar","filing":"0001213900-20-000384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020000384/ownership.xml","form_type":"4"}},{"id":3400987,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:17:13.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":12599,"source":{"system":"sec-edgar","filing":"0001213900-19-019543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019019543/ownership.xml","form_type":"4"}},{"id":3573980,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T20:21:44.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":6347,"source":{"system":"sec-edgar","filing":"0001213900-19-005245","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019005245/ownership.xml","form_type":"4"}},{"id":3793601,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-10T21:20:17.000Z","date":"2018-10-08","kind":"purchase","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":4263,"source":{"system":"sec-edgar","filing":"0001213900-18-013768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018013768/ownership.xml","form_type":"4"}},{"id":3874873,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T18:43:17.000Z","date":"2018-06-29","kind":"purchase","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":2179,"source":{"system":"sec-edgar","filing":"0001213900-18-008680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008680/ownership.xml","form_type":"4"}},{"id":3881350,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-28T16:55:36.000Z","date":"2018-06-27","kind":"purchase","acquired":true,"shares":95,"price":9.95,"value":945.25,"ownership":{"direct":true},"balance_after":95,"source":{"system":"sec-edgar","filing":"0001213900-18-008414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008414/ownership.xml","form_type":"4"}}]}